Legal Opinion
Commonwealth ex rel. Conway v. Janssen Pharmaceuticals, Inc.
District Court, W.D. Kentucky
Decided October 16, 2013No. Civil Action No. 3:13-CV-00624-JHMPublishedCited by 1 opinion
1Opinion of the Court
Memorandum Opinion and Order
JOSEPH H. McKINLEY, JR., Chief Judge.
This matter is before the Court on the Commonwealth’s Motion to Remand [DN 10]. Fully briefed, this matter is ripe for decision. For the following reasons, the motion is GRANTED.
I. Background
This action focuses on Risperdal®, a prescription antipsychotic medicine which has been approved by the Food and Drug Administration (“FDA”). Since its launch in 1994, Defendants have advertised, sold, marketed, and distributed Risperdal to Kentucky’s health care providers, pharmacies, and consumers. (Compl. [DN 1-2] *790¶¶ 1-5.) On May 14,…
2Cases cited7 opinions
- Merrell Dow Pharmaceuticals Inc. v. Thompson Ex Rel. ThompsonSupreme Court of the United States · 1986
- Grable & Sons Metal Products, Inc. v. Darue Engineering & ManufacturingSupreme Court of the United States · 2005
- Empire Healthchoice Assurance, Inc. v. McVeighSupreme Court of the United States · 2006
- Leroy Alexander v. Electronic Data Systems Corporation James Jeros Steven Brechtelsbauer Jane DoeCourt of Appeals for the Sixth Circuit · 1994
- Mikulski v. Centerior Energy Corp.Court of Appeals for the Sixth Circuit · 2007
2 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- State of Georgia ex rel. v. Elite Integrated Medical, LLCDistrict Court, N.D. Georgia · 2021